LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...
Emboline, Inc., a privately held medical technology company developing embolic protection solutions for structural heart procedures, today announced positive results from its pivotal PROTECT H2H ...
Splinting no better than a simple "placebo" bandage ...
Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony ...
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
As reported by the Twin Cities Business Journal, the $50 million infusion was announced March 25 and will be used to move the ...
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
Medicinal cannabinoids show little strong evidence of helping mental health or substance use disorders, University of Sydney ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...